SCHEMBL6436345

SCHEMBL6436345

Cc1nc2ccc(C(=O)Nc3ccc(NC(=O)c4cncc(Br)c4)cc3)cc2cc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.57
HTT P42858 5/20 0.57
NPC1 O15118 7/20 0.56
KMT2A Q03164 6/20 0.55
MEN1 O00255 5/20 0.55
MAPT P10636 4/20 0.55
ALDH1A1 P00352 3/20 0.55
MAPK1 P28482 2/20 0.55
KDM4E B2RXH2 2/20 0.55
ROCK2 O75116 1/20 0.54
GAA P10253 1/20 0.54
ALOX12 P18054 1/20 0.54
ROCK1 Q13464 1/20 0.54
RAB9A P51151 5/20 0.54
TSHR P16473 1/20 0.54
RXFP1 Q9HBX9 1/20 0.49
KDR P35968 1/20 0.49
TP53 P04637 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3241423 0.87 DNMT1 (0.51) SMN1; SMN2NPC1KMT2AMEN1MAPT
SCHEMBL3240191 0.82 MMP9 (0.57) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL6439246 0.80 RAB9A (0.56) SMN1; SMN2NPC1KMT2AMEN1MAPT
SCHEMBL14880166 0.76 SMN1; SMN2 (0.73) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL6436343 0.76 NPC1 (0.56) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL3237959 0.75 SMN1; SMN2 (0.53) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL5558427 0.72 MMP9 (0.49) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL14992382 0.72 HTT (0.73) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL15140299 0.71 HTT (1.00) SMN1; SMN2HTTNPC1KMT2AMEN1
SCHEMBL485711 0.71 MEN1 (0.82) SMN1; SMN2HTTNPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509516-A1 INHIBITORS OF THE GPIB -VWF INTERACTION, THEIR PREPARATION AND USE Aventis Pharma Deutschland GmbH (DE) 2005-03-02 EP disclosed
WO-2003104221-A1 INHIBITORS OF THE GPIB -VWF INTERACTION, THEIR PREPARATION AND USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-18 WO disclosed